Oncology Diagnostics Panel Session
In A Path to Success in Diagnostics, our panelists discuss some of today’s leading technologies and leading companies in various verticals of the Oncology diagnostics market. You’ll also hear from an emerging firm regarding the next generation of market leaders.
- Shailesh Maingi – Founder and CEO, Kineticos
- Eric Mayer – CEO, EDP Biotech
- Sandra Dunn – CEO, Phoenix Molecular
- Brian Kelly – Global Director, Diagnostic Partnering, Thermo Fisher
- Part 1 – Can Diagnostics Keep Up with Pharma
- Part 2 – Making Up for Unfavorable Reimbursement
- Part 3 – The Impact of I/O on Oncology Diagnostics
Subscribe to Kineticos to receive weekly emails containing insightful content.